Health Care: Drugs

Regulus Therapeutics Inc (RGLS: NASDAQ)

$6.23 -0.29 | -4.45%
07/28/14 - 11:17 AM ET
Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 17.81M 40.55M 9.18M
Receivables 79.00K 0.00 0.00
Inventories 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00
Total Current Assets 117.18M 98.93M 38.67M
Property, Plant & Equipment, Gross 7.50M 5.75M 4.61M
Accumulated Depreciation & Depletion 3.73M 2.44M 1.50M
Property, Plant & Equipment, Net 3.77M 3.31M 3.11M
Intangibles 1.13M 1.15M 980.00K
Other Non-Current Assets 987.00K 125.00K 125.00K
Total Non-Current Assets 5.88M 4.59M 4.22M
Liabilities & Shareholder Equity
Total Assets 123.06M 103.52M 42.88M
Accounts Payable 1.17M 311.00K 501.00K
Short Term Debt 0.00 0.00 377.00K
Other Current Liabilities 0.00 0.00 206.00K
Total Current Liabilities 10.37M 12.77M 12.85M
Long Term Debt 11.28M 10.13M 10.00M
Deferred Income Taxes 0.00 0.00 446.00K
Other Non-Current Liabilities 7.96M 18.52M 17.95M
Minority Interest 0.00 0.00 0.00
Total Non-Current Liabilities 19.24M 28.66M 71.52M
Total Liabilities 29.61M 41.42M 84.38M
Preferred Stock Equity 0.00 0.00 0.00
Common Stock Equity 93.46M 62.09M -41.49M
Common Par 42.00K 36.00K 0.00
Additional Paid In Capital 172.52M 122.53M 1.58M
Cumulative Translation Adjustment 0.00 0.00 0.00
Retained Earnings -79.09M -60.42M -43.01M
Treasury Stock 0.00 0.00 0.00
Other Equity Adjustments -16.00K -52.00K -67.00K
Total Capitalization 104.74M 72.23M -31.49M
Total Equity 93.46M 62.09M -41.49M
Total Liabilities & Stock Equity 123.06M 103.52M 42.88M
Total Common Shares Outstanding 41.79M 35.83M 34.13M
Preferred Shares 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00
Basic Weighted Shares Outstanding 38.48M 8.21M 15.18M
Diluted Weighted Shares Outstanding 38.48M 8.21M 15.18M
Number of Employees 76 66 NA
Number of Part-Time Employees 0 6 NA

Portfolios with RGLS

Latest RGLS Headlines from TheStreet

More Financial News for RGLS

Press Releases for RGLS

See All Press Releases

Partner Headlines for RGLS

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter